Supriya Lifescience Ltd - 543434 - Unaudited Financial Results For The Quarter And Six Months Ended September 30, 2022 (Revised)
We hereby enclose the following: 1. Copy of the Revised Unaudited Financial Results of the Company for the quarter and six months ended September 30, 2022 along with the Limited Review report issued by Statutory Auditor; Supriya Lifescience Ltd - 543434 - Unaudited Financial Results For The Quarter And Six Months Ended September 30, 2022.
We hereby enclose the following: 1. Copy of the Unaudited Financial Results of the Company for the quarter and six months ended September 30, 2022 along with the Limited Review report issued by Statutory Auditor; Supriya Lifescience Ltd - 543434 - Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Thursday, November 10, 2022, inter-alia, has: 1. Considered and approved the Unaudited Financial Results for the Quarter and six months ended September 30, 2022. 2. Approved appointment of M/s. DSM & Associates, Practising Company Secretaries as Secretarial Auditor for the financial year 2022-23; 3. Approved appointment of M/s. Nair's & Panicker's, Audit & Advisory Services, as Internal Auditor for the financial year 2022-23; Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Friday, November 11, 2022 at 4.00 P.M. IST to discuss operational and financial performance of the Company for the quarter and half year ended September 30, 2022. The invite giving requisite details including the pre-registration link and dial-in details is attached herewith. Supriya Lifescience Ltd - 543434 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2022 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. Supriya Lifescience Ltd - 543434 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Shweta SinghDesignation :- Company Secretary and Compliance Officer Supriya Lifescience Ltd - 543434 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a duly signed Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 received from Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended September 30, 2022. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to the relevant provisions of the SEBI Listing Regulations, we are enclosing herewith Press Release for Appointment of Mr. Rajeev Kumar Jain as Chief Executive Officer & Key Managerial Personnel w.e.f. October 3, 2022. Supriya Lifescience Ltd - 543434 - Closure of Trading Window
In accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time and the Company's Code of Conduct to Regulate, Monitor and Report Trading in Securities by Insiders (hereinafter referred to as the "Prohibition of Insider Trading Code"), the Trading window for dealing in the Securities of the Company for all the Insiders, Designated Persons (including their immediate relatives), as defined in the Code, shall remain closed from October 01, 2022 till the expiry of 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analyst/Institutional Investors on September 29, 2022 via video conference.